Tet2 disruption improves Kymriah efficacy

In a Nature study, researchers at the University of Pennsylvania identified a patient with an enhanced response to CAR T therapy Kymriah tisagenlecleucel, and suggested targeting the epigenome by inhibiting Tet2 could improve the

Read the full 349 word article

User Sign In